Showing results (1-10 of 552) with videos related to
Sort By:
Pageof 56
International Journal of Antimicrobial Agents|October 21, 1999
Fusidic acid in bone and joint infectionsB Atkins, T GottliebClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2000
Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adultT Solano, B Atkins, E Tambosis, et al.Anaesthesia and Intensive Care|February 1, 1993
Hazards of bacterial contamination of blood productsT GottliebClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Cytokine-based therapy and biochemotherapy for advanced melanomaMichael B AtkinsMedical Oncology (Northwood, London, England)|January 24, 2009
Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapyMichael B AtkinsHematology/Oncology Clinics of North America|October 6, 1998
Immunotherapy and experimental approaches for metastatic melanomaM B AtkinsCurrent Opinion in Oncology|March 1, 1997
The treatment of metastatic melanoma with chemotherapy and biologicsM B AtkinsSports Medicine (Auckland, N.Z.)|March 30, 2000
Infectious diseases in rugby players: incidence, treatment and preventionA Stacey, B AtkinsThe Journal of Antimicrobial Chemotherapy|August 13, 1998
The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR)T Gottlieb, D MitchellPageof 56